MOLECULAR PHARMING NOW ON THE BRINK OF TAKEOFF. “After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europe. And there has been significant investment into manufacturing facilities around the world.””
”
http://lnkd.in/d8p-GH2
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022